Guru Ownership Trend
Guru Analysis for Palvella Therapeutics, Inc. (PVLA)
Palvella Therapeutics, Inc. (PVLA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $16.03 M.
Top institutional holders include Steven Cohen and Chuck Royce.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $34.19 M net outflow during the quarter.
On the selling side, Steven Cohen reduced exposure by 75.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Palvella Therapeutics, Inc. (PVLA)
Major holders include Steven Cohen ($8.09 M), Chuck Royce ($3.14 M), Renaissance Technologies (RenTech) ($2.36 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 129,837 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $34.19 M, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited PVLA. The total reported sell value was $34.19 M.
No tracked managers opened new positions or increased their holdings in PVLA during the most recent reporting period.